BioPharma Resources

Drug Trial Radar · NCT07190209

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

A Phase 2b/Phase 3, Randomized, Double-blind, Placebocontrolled, Multicenter Study, to Investigate the Efficacy and Safety of Lunsekimig in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 942 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

942

Planned (sponsor's estimate)

Start

Sep 16, 2025

Primary completion

Nov 27, 2029

Study completion Jan 22, 2030

Sponsor

Lead sponsor
SanofiSanofi (SNY)
Sponsor type
Industry
First posted
Sep 24, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 40 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a parallel, Phase 2b/Phase 3, 3-arm study to investigate the efficacy, safety, and tolerability of subcutaneous (SC) treatment with lunsekimig compared with placebo in adult participants (aged 40 to 80 years, inclusive) with inadequately controlled Chronic obstructive pulmonary disease (COPD) characterized by an eosinophilic phenotype. Participation to the study consists of 3 periods: * Screening period of up to 4 weeks * Randomized intervention period of approximately 48 weeks * Follow-up period: Approximately 8 weeks The study duration will be up to 60 weeks.

Conditions

  • Chronic Obstructive Pulmonary Disease

Interventions

  • LunsekimigDrug

    Pharmaceutical form: solution for injection in prefilled syringe. Route of administration: Subcutaneous injection

  • PlaceboDrug

    Pharmaceutical form: solution for injection. Route of administration: Subcutaneous injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Annualized rate of moderate-to-severe chronic obstructive pulmonary disease (COPD) exacerbationsTime frame: From Baseline up to 48 weeks

Locations

322 sites in 25 countries. Site status is shown where the registry gives one.

  • Chandler Clinical Research Trials- Site Number : 8400025

    Chandler, Arizona · Completed

  • Pulmonary Associates - Phoenix - East Bell Road- Site Number : 8400114

    Phoenix, Arizona · Recruiting

  • Epic Medical Research - Surprise- Site Number : 8400096

    Surprise, Arizona · Recruiting

  • IMAX Clinical Trials- Site Number : 8400109

    La Palma, California · Recruiting

  • Long Beach Research Institute- Site Number : 8400027

    Long Beach, California · Recruiting

  • Downtown L.A. Research Center- Site Number : 8400009

    Los Angeles, California · Recruiting

  • Newport Native MD- Site Number : 8400003

    Newport Beach, California · Recruiting

  • Paradigm Research - Redding- Site Number : 8400108

    Redding, California · Recruiting

  • Amicis Research Center - Valencia- Site Number : 8400119

    Valencia, California · Recruiting

  • Helix Biomedics- Site Number : 8400065

    Boynton Beach, Florida · Recruiting

  • Beautiful Minds Clinical Research Center- Site Number : 8400017

    Cutler Bay, Florida · Recruiting

  • Solution Clinical Research- Site Number : 8400039

    Doral, Florida · Completed

  • Eastern Medical Group Research- Site Number : 8400020

    Fort Myers, Florida · Recruiting

  • Premier Medical Associates- Site Number : 8400012

    Lady Lake, Florida · Completed

  • University of Miami Dermatology Clinical Trials Unit- Site Number : 8400078

    Miami, Florida · Recruiting

  • MCR Research- Site Number : 8400004

    Miami, Florida · Recruiting

  • Nuren Medical & Research Center- Site Number : 8400030

    Miami, Florida · Recruiting

  • My Community Research Center- Site Number : 8400164

    Miami, Florida · Recruiting

  • Reed Medical Research Corp- Site Number : 8400167

    Miami, Florida · Recruiting

  • Deluxe Health Center- Site Number : 8400010

    Miami Lakes, Florida · Recruiting

  • Omega Research Consultants - Orlando - Forest City- Site Number : 8400015

    Orlando, Florida · Recruiting

  • Pharmakon Medical Research- Site Number : 8400156

    Palm Beach Gardens, Florida · Recruiting

  • Broward Research Center - Pembroke Pines- Site Number : 8400053

    Pembroke Pines, Florida · Recruiting

  • Clinical Research Trials of Florida- Site Number : 8400011

    Tampa, Florida · Recruiting

  • Deluxe Health Center-Tampa- Site Number : 8400056

    Tampa, Florida · Recruiting

  • Private Practice - Dr. David Kavtaradze- Site Number : 8400006

    Cordele, Georgia · Recruiting

  • Primeway Clinical Research- Site Number : 8400121

    Fayetteville, Georgia · Recruiting

  • University of Illinois-Chicago - College of Medicine- Site Number : 8400055

    Chicago, Illinois · Recruiting

  • Avicenna Clinical Research- Site Number : 8400126

    Chicago Ridge, Illinois · Recruiting

  • NorthShore Medical Group - Evanston ( Endeavor Health)- Site Number : 8400073

    Evanston, Illinois · Recruiting

  • Indy Clinical Research- Site Number : 8400071

    Indianapolis, Indiana · Recruiting

  • University of Kansas Medical Center- Site Number : 8400054

    Kansas City, Kansas · Recruiting

  • University of Michigan Health System - Ann Arbor- Site Number : 8400090

    Ann Arbor, Michigan · Recruiting

  • Veritas Clinical Research- Site Number : 8400007

    Madison Heights, Michigan · Recruiting

  • Mayo Clinic in Rochester - Minnesota- Site Number : 8400005

    Rochester, Minnesota · Recruiting

  • Henderson Clinical Trials- Site Number : 8400026

    Henderson, Nevada · Recruiting

  • Sanmora Bespoke Clinical Research Solutions- Site Number : 8400144

    East Orange, New Jersey · Recruiting

  • New York Hospital Queens- Site Number : 8400058

    Flushing, New York · Recruiting

  • Duke Asthma, Allergy and Airway Center- Site Number : 8400047

    Durham, North Carolina · Recruiting

  • Advanced Respiratory and Sleep Medicine - Hickory- Site Number : 8400013

    Hickory, North Carolina · Recruiting

Showing 40 of 322 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.